September 30, 2016

CORRECTING and REPLACING – Novocure to Report Third Quarter 2016 Financial Results

ST. HELIER, Jersey, Sept. 30, 2016 (GLOBE NEWSWIRE) — In a press release issued under the same headline earlier today by Novocure, Ltd. (Nasdaq:NVCR), please note that the first paragraph should say “the three and nine months ended Sept. 30, 2016” rather than “the three and six months ended Sept. Read More
learn more
September 30, 2016

CORRECTING and REPLACING – Novocure to Report Third Quarter 2016 Financial Results

ST. HELIER, Jersey, Sept. 30, 2016 (GLOBE NEWSWIRE) — In a press release issued under the same headline earlier today by Novocure, Ltd. (Nasdaq:NVCR), please note that the first paragraph should say “the three and nine months ended Sept. 30, 2016” rather than “the three and six months ended Sept. Read More
learn more
September 30, 2016

Novocure to Report Third Quarter 2016 Financial Results

ST. HELIER, Jersey, Sept. 30, 2016 (GLOBE NEWSWIRE) — Novocure (NASDAQ:NVCR) announced today that it will report financial results for the third quarter 2016 on Wednesday, Nov. 2, 2016, before the open of U.S.-based financial markets. Novocure management will host a conference call and webcast to discuss its financial results… Read More
learn more
September 30, 2016

Novocure to Report Third Quarter 2016 Financial Results

ST. HELIER, Jersey, Sept. 30, 2016 (GLOBE NEWSWIRE) — Novocure (NASDAQ:NVCR) announced today that it will report financial results for the third quarter 2016 on Wednesday, Nov. 2, 2016, before the open of U.S.-based financial markets. Novocure management will host a conference call and webcast to discuss its financial results… Read More
learn more
September 30, 2016

Novocure to Report Third Quarter 2016 Financial Results

ST. HELIER, Jersey, Sept. 30, 2016 (GLOBE NEWSWIRE) — Novocure (NASDAQ:NVCR) announced today that it will report financial results for the third quarter 2016 on Wednesday, Nov. 2, 2016, before the open of U.S.-based financial markets. Novocure management will host a conference call and webcast to discuss its financial results… Read More
learn more
September 19, 2016

CNS Oncology Publishes Tumor Treating Fields Treatment Planning and Patient Follow-up Guidelines in Glioblastoma

Guidelines provide a framework for using the NovoTAL System to optimize Tumor Treating Fields intensity in Optune patients Guidelines provide a framework for using the NovoTAL System to optimize Tumor Treating Fields intensity in Optune patients Tumor Treating Fields extend overall survival when combined… Read More
learn more
September 19, 2016

CNS Oncology Publishes Tumor Treating Fields Treatment Planning and Patient Follow-up Guidelines in Glioblastoma

Guidelines provide a framework for using the NovoTAL System to optimize Tumor Treating Fields intensity in Optune patients Guidelines provide a framework for using the NovoTAL System to optimize Tumor Treating Fields intensity in Optune patients Tumor Treating Fields extend overall survival when combined… Read More
learn more
September 19, 2016

CNS Oncology Publishes Tumor Treating Fields Treatment Planning and Patient Follow-up Guidelines in Glioblastoma

Guidelines provide a framework for using the NovoTAL System to optimize Tumor Treating Fields intensity in Optune patients Guidelines provide a framework for using the NovoTAL System to optimize Tumor Treating Fields intensity in Optune patients Tumor Treating Fields extend overall survival when combined… Read More
learn more
September 15, 2016

Novocure’s Executive Chairman William Doyle to Present on Tumor Treating Fields at New York Academy of Sciences’ Symposium on Bioelectronic Medicine

The NYAS’ 13th Key Symposium 2016: Bioelectronic Medicine – Technology Targeting Molecular Mechanisms brings together thought leaders to advance this growing frontier of patient care September 15, 2016 07:30 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ:… Read More
learn more
September 15, 2016

Novocure’s Executive Chairman William Doyle to Present on Tumor Treating Fields at New York Academy of Sciences’ Symposium on Bioelectronic Medicine

The NYAS’ 13th Key Symposium 2016: Bioelectronic Medicine – Technology Targeting Molecular Mechanisms brings together thought leaders to advance this growing frontier of patient care September 15, 2016 07:30 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ:… Read More
learn more